Sacituzumab Govitecan and Bevacizumab for NSCLC Brain Metastases

Clinical trial NCT06401824 · RECRUITING

Trial details

NCT number: NCT06401824
Sponsor: Maastricht University Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

NSCLC Stage IV Brain Metastases, Adult

Start date: 2025-04-24
Primary completion: 2026-11-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.